ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Information Available By Fax

May 3, 1991

No Benefit To Kidney Removal For Elderly With Kidney Cancer

May 28, 2010

“Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers

July 7, 1989

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013